Medipyxis
blog9 min read

Wound Care in Hospice: When Healing Isn't the Goal

How wound care shifts in hospice and palliative settings — comfort-focused management, odor and pain control, non-healing-intent documentation, and billing.

D

Damon Ebanks

Medipyxis

Wound Care in Hospice: When Healing Isn't the Goal

Wound Care in Hospice and Palliative Settings: When Healing Isn't the Goal

Wound care hospice patients require a fundamentally different approach, yet most wound care training, documentation frameworks, and billing structures assume the goal is wound closure. Measure the wound, debride the wound, apply advanced therapies, track percentage reduction, achieve closure. The entire system is designed around healing trajectories.

But for patients in hospice or palliative care, healing is not the goal — and may not be physiologically possible. The body is shutting down. The wound is a symptom of that process, not a problem to be solved independently of it. The wound care clinician's role shifts fundamentally: from healing the wound to managing the wound so it does not make the patient's remaining time worse than it needs to be.

This shift requires a different clinical framework, a different documentation approach, and a different relationship with the concept of "medical necessity."


Why Wounds Occur in End-of-Life Care

Wounds in hospice and palliative patients are driven by the physiology of dying, not by care failure.

Pressure injuries: As patients become immobile, nutritional status declines, and tissue perfusion decreases, pressure injuries develop. Approximately 50% of hospice patients develop pressure injuries in the last two weeks of life. These are often unavoidable — the skin failure reflects systemic organ failure.

Kennedy Terminal Ulcers (KTUs): A specific subset of skin failure that presents as a rapidly developing pressure injury — typically on the sacrum — that appears in the final days to weeks of life. KTUs are characterized by their sudden onset, irregular margins, and rapid progression. They are not caused by inadequate pressure redistribution. They are a sign that the body's largest organ is failing along with everything else. Recognizing a KTU is clinically important because it reframes expectations for the patient, family, and care team.

Malignant wounds (fungating tumors): Cancers that erode through the skin create wounds that cannot heal while the underlying malignancy persists. In palliative patients who are not pursuing curative cancer treatment, these wounds require management for symptom control — not healing.

Vascular wounds in patients declining intervention: Some patients with critical limb ischemia decline revascularization — either because of comorbidities, age, or personal choice. These ischemic wounds will not heal without perfusion restoration. The wound care goal shifts to maintaining the limb as long as possible, managing pain, and preventing infection that would accelerate decline.


The Palliative Wound Care Framework

Palliative wound management is organized around three priorities, in this order:

1. Pain Management

Wound-related pain is the most impactful symptom for hospice patients. It is also the most addressable.

Pain management strategies:

  • Topical anesthetics applied to the wound bed before dressing changes (lidocaine gel, compounded topical preparations). This eliminates the dressing-change pain that many hospice patients dread.
  • Pre-medication with systemic analgesics (opioids, if consistent with the hospice plan of care) timed 30-60 minutes before wound care visits.
  • Non-adherent dressings that do not bond to the wound bed. Removing a stuck dressing is one of the most painful procedures a wound patient experiences. Silicone-faced foams, petroleum-impregnated gauze, and non-adherent contact layers eliminate this entirely.
  • Reduced debridement. In a palliative setting, sharp debridement of necrotic tissue is only indicated if the necrotic tissue is causing pain, infection, or odor. Autolytic debridement (moisture-retentive dressings that soften necrotic tissue over time) is preferred when debridement is needed. Aggressive surgical debridement of a wound that will not heal causes pain without clinical benefit.
  • Wound care visit frequency reduction. If the wound is stable and the dressing can remain in place for 3-5 days, reduce visit frequency. Every wound care visit in a hospice patient is a potential pain event. Fewer visits with appropriate dressings is often better care, not worse care.

2. Odor Control

Wound odor — particularly from malignant wounds and infected pressure injuries — has a devastating impact on the patient's dignity, family presence, and quality of life. Families may avoid the patient's room. The patient may feel shame. Odor management is a clinical priority, not a cosmetic one.

Odor management strategies:

  • Metronidazole (topical). Crushed metronidazole tablets applied to the wound bed or topical metronidazole gel is the most effective intervention for anaerobic bacterial odor. This targets the anaerobic bacteria that produce the sulfur compounds responsible for wound malodor.
  • Activated charcoal dressings. Charcoal-containing dressings absorb volatile odor compounds. Used as a secondary dressing layer over the primary wound dressing.
  • Cadexomer iodine for infected wounds where odor is driven by bacterial bioburden. Provides antimicrobial activity and absorbs exudate.
  • Wound cleansing with each dressing change. Gentle irrigation with normal saline or wound cleanser removes surface bacteria and wound debris that contribute to odor.
  • Environmental measures. Activated charcoal placed near the wound (not on the wound), essential oil diffusers, and room ventilation can supplement wound-directed odor management. These are adjuncts — they do not replace wound-directed interventions.

3. Exudate Management

Heavily exudative wounds — common in malignant wounds and some pressure injuries — cause maceration of surrounding skin, dressing failures, soiled clothing and bedding, and patient distress.

Exudate management strategies:

  • Superabsorbent dressings that lock exudate away from the wound surface and periwound skin. These reduce dressing change frequency and protect intact skin.
  • Skin protectants (zinc oxide barriers, dimethicone-based protectants) applied to periwound skin to prevent maceration and moisture-associated skin damage.
  • Pouching systems for wounds with high-volume output. Ostomy-type pouching can be adapted for wound drainage management, containing exudate and protecting surrounding skin.
  • Negative pressure wound therapy (NPWT) in select palliative cases — primarily for exudate management rather than healing. NPWT can reduce dressing changes and manage high-output wounds, but must be weighed against device burden on the patient.

Documentation for Non-Healing-Intent Care

Documenting palliative wound care requires a fundamental shift from the standard wound care documentation framework. The documentation must support the clinical rationale for wound management without a healing goal.

Key documentation elements:

  • Goals of care statement. Document that the patient is receiving hospice or palliative care, that wound healing is not the clinical goal, and that wound management is directed at symptom control (pain, odor, exudate, infection prevention).
  • Patient/family discussion. Document that the patient and/or family understand the wound will not heal and that care is focused on comfort. This conversation is both clinically important and legally protective.
  • Symptom-based assessment. Instead of tracking wound size reduction (which implies a healing goal), document the symptoms being managed: pain level before and after wound care, odor status, exudate volume, periwound skin integrity, and infection signs.
  • Wound stability. For non-healing wounds, document whether the wound is stable (not deteriorating) or progressing (expanding, deepening, developing new complications). Stability in a palliative wound is a positive outcome.
  • Kennedy Terminal Ulcer identification. If a KTU is suspected, document the clinical features that support the diagnosis: sudden onset, sacral location, irregular margins, rapid progression, temporal correlation with overall clinical decline. KTU documentation reframes the wound from "preventable pressure injury" to "expected skin failure in the dying process."

Billing Considerations

Billing for palliative wound care requires understanding what is and is not billable when healing is not the goal.

Under Medicare hospice benefit:

When a patient is enrolled in Medicare hospice, the hospice agency is responsible for all care related to the terminal diagnosis and related conditions. If the wound is related to the terminal diagnosis (pressure injury from immobility due to terminal cancer, for example), wound care is typically the hospice agency's responsibility — and the wound care clinician may be contracted by the hospice agency to provide this service.

Wounds unrelated to the hospice diagnosis may be billed to Medicare Part B separately, but this requires careful documentation that the wound is not related to the terminal condition.

Under palliative care (non-hospice):

Patients receiving palliative care who are NOT enrolled in hospice can receive wound care services billed under standard Medicare Part B. The documentation must support medical necessity — which in palliative wound care means symptom management, infection prevention, and maintaining skin integrity, not wound closure.

Debridement in palliative settings:

Debridement CPT codes (97597, 97598, 11042-11047) are billable when debridement is medically necessary — even in palliative patients. The medical necessity justification shifts from "preparing the wound bed for healing" to "removing necrotic tissue that is causing pain, odor, or infection." Document the symptom-based rationale clearly.

For CPT code details, see the Wound Care CPT Codes 2026 Guide.


Working with Wound Care Hospice Agencies

Many wound care practices develop hospice agency partnerships as a dedicated service line. Hospice agencies need wound care expertise but often do not have wound care specialists on staff.

Partnership models:

  • Contracted specialist. The wound care clinician contracts directly with the hospice agency to provide wound care services for their patients. The hospice bills Medicare. The wound care clinician bills the hospice agency per visit or per month.
  • Consulting role. The wound care clinician provides wound care recommendations and treatment plans that hospice nurses execute. This reduces visit frequency while ensuring expert wound management.
  • Education and training. Provide wound care training to hospice nursing staff — specifically palliative wound care techniques (non-adherent dressings, odor management, pain-minimizing dressing changes). This builds the relationship and generates referrals for complex wounds that exceed hospice nursing capability.

Key Takeaways

  • Palliative wound care shifts the goal from closure to comfort -- pain management, odor control, and infection prevention replace healing trajectory as primary outcomes
  • Billing for wound care in hospice requires careful coordination: wound care related to the terminal diagnosis is typically covered under the hospice per diem, while unrelated wound care may be billed separately to Medicare Part B
  • Document the palliative intent clearly in every note to distinguish comfort-focused wound care from curative treatment
  • Build hospice referral partnerships by positioning wound care as a quality-of-life service for patients and families, not a competing clinical intervention

Related: Wound Care CPT Codes 2026 | Wound Care Referral Strategy | Home Health Partnership Model